
Rituximab (100mg)
Active composition
Rituximab binds to CD20 on B-cells, inducing apoptosis and mediating antibody-dependent cellular cytotoxicity.
Medical applications
Enfiera 100mg Injection contains Rituximab, a monoclonal antibody medication designed to target specific immune system cells. It works by binding to certain proteins present on the surface of particular immune cells and influencing their activity. This action helps regulate immune responses and supports treatment strategies in conditions where immune system activity requires control. The injection is administered by a qualified healthcare professional in a clinical setting to ensure safe and effective treatment. The dosage and treatment schedule are determined by a healthcare provider based on individual medical needs and response to therapy. Regular monitoring may be required during treatment to evaluate effectiveness and maintain safety. When used under proper medical supervision, Enfiera Injection helps support controlled immune system activity and contributes to overall medical treatment management.
Monoclonal antibody (mAb)
Important precautions
Based on clinical trials and patient reports.
Overall Tolerance
Common Side Effects
Enfiera 100mg Injection may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
High Risk
Enfiera 100mg Injection is probably safe to use during breastfeeding. Limited human data suggests that the drug does not represent any significant risk to the baby.
Medical Advice
Enfiera 100mg Injection is probably safe to use in patients with kidney disease. Limited data available suggests that dose adjustment of Enfiera 100mg Injection may not be needed in these patients. Please consult your doctor.
Exercise Caution
It is not known whether Enfiera 100mg Injection alters the ability to drive. Do not drive if you experience any symptoms that affect your ability to concentrate and react.
Consult Doctor
There is limited information available on the use of Enfiera 100mg Injection in patients with liver disease. Please consult your doctor. Use of Enfiera 100mg Injection is not recommended in patients with the active liver disease or those who had viral hepatitis as it can reactivate the infection.
Regular Checkup
0 reviews for Enfiera 100mg Injection

Rituximab (100mg)
Cheaper alternative availability
This medicine doesn't have a cheaper alternative with the same composition. Our health advisors can help you find other savings options based on your prescription.
Active composition
Rituximab binds to CD20 on B-cells, inducing apoptosis and mediating antibody-dependent cellular cytotoxicity.
Medical applications
Enfiera 100mg Injection contains Rituximab, a monoclonal antibody medication designed to target specific immune system cells. It works by binding to certain proteins present on the surface of particular immune cells and influencing their activity. This action helps regulate immune responses and supports treatment strategies in conditions where immune system activity requires control. The injection is administered by a qualified healthcare professional in a clinical setting to ensure safe and effective treatment. The dosage and treatment schedule are determined by a healthcare provider based on individual medical needs and response to therapy. Regular monitoring may be required during treatment to evaluate effectiveness and maintain safety. When used under proper medical supervision, Enfiera Injection helps support controlled immune system activity and contributes to overall medical treatment management.
Monoclonal antibody (mAb)
Important precautions
Based on clinical trials and patient reports.
Overall Tolerance
Common Side Effects
Enfiera 100mg Injection may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
High Risk
Enfiera 100mg Injection is probably safe to use during breastfeeding. Limited human data suggests that the drug does not represent any significant risk to the baby.
Medical Advice
Enfiera 100mg Injection is probably safe to use in patients with kidney disease. Limited data available suggests that dose adjustment of Enfiera 100mg Injection may not be needed in these patients. Please consult your doctor.
Exercise Caution
It is not known whether Enfiera 100mg Injection alters the ability to drive. Do not drive if you experience any symptoms that affect your ability to concentrate and react.
Consult Doctor
There is limited information available on the use of Enfiera 100mg Injection in patients with liver disease. Please consult your doctor. Use of Enfiera 100mg Injection is not recommended in patients with the active liver disease or those who had viral hepatitis as it can reactivate the infection.
Regular Checkup
0 reviews for Enfiera 100mg Injection















